Avandia (Rosiglitazone)

Rosiglitazone is a medication used to help manage type 2 diabetes. It works by improving how your body uses insulin, which helps lower your blood sugar levels. It's taken as a pill, usually once a day.

Brand names:Avandia
Medication

What people taking Avandia (Rosiglitazone) report

Every report comes from a Lived member, sent anonymously.

Have you tried Avandia (Rosiglitazone) for Type 2 Diabetes?

NameHow it went

About Avandia (Rosiglitazone)

What It's For

Rosiglitazone, sold under the brand name Avandia, is a prescription tablet that was approved to lower blood sugar in adults with type 2 diabetes, alongside diet and exercise. It could be used on its own or with other diabetes pills such as metformin, and it was also sold in combination tablets (Avandamet with metformin, and Avandaryl with glimepiride). It is not a treatment for type 1 diabetes or diabetic ketoacidosis, because it only works when the body still makes some of its own insulin. Rosiglitazone is no longer sold in the United States: records at the US Food and Drug Administration (FDA) list Avandia, its combination products and its generics as discontinued, and the agency determined the brand was not withdrawn for safety reasons. In Europe, regulators suspended it in 2010 after concluding that its possible heart risks outweighed its benefits. Most people who once took it have moved to other diabetes medicines. The closely related drug pioglitazone (Actos) remains available in the US.

How It Works

In type 2 diabetes, the body usually still makes insulin, but muscle, fat and liver cells respond to it less well. This is called insulin resistance, and it leaves more sugar circulating in the blood. Rosiglitazone belongs to a class of medicines called thiazolidinediones. It switches on a receptor inside cells that controls genes involved in how the body handles sugar and fat. The result is that tissues respond better to the insulin the body already makes, so more sugar moves out of the blood. Because it does not make the pancreas release more insulin, it rarely causes low blood sugar on its own. The same receptor also affects how the body holds on to salt and water, which helps explain its main drawback: fluid retention.

Dosage & Administration

Rosiglitazone was taken by mouth, usually starting at 4 mg a day, either once daily or split into two doses, with or without food. If blood sugar had not improved enough after 8 to 12 weeks, the dose could be raised, but the total was not meant to exceed 8 mg a day. Each increase called for watching closely for swelling and weight gain. Liver blood tests were done before starting and from time to time afterward. A missed dose could be taken when remembered unless the next one was nearly due; two doses were not to be taken together. Anyone who still has rosiglitazone, or obtains it outside the US, should not stop or change it without a plan from their prescriber, since blood sugar can rise when a diabetes medicine is stopped.

Side Effects

Swelling of the ankles or legs and weight gain are the side effects people most often notice. Both tend to be larger at higher doses and when rosiglitazone is combined with insulin, and the weight gain reflects both retained fluid and added body fat. Cold-like symptoms and headaches were also common in trials. Long-term studies found more broken bones, mostly in the upper arm, hand and foot and especially in women, and a mild drop in red blood cell counts. Some effects need a prompt call to the prescriber. Rapid weight gain, new or worsening swelling, shortness of breath (especially when lying down) or unusual tiredness can signal fluid building up toward heart failure. Unexplained nausea, vomiting, belly pain, loss of appetite, dark urine or yellowing of the skin or eyes can point to a liver problem. Any change in vision should also be reported quickly, because rosiglitazone has been linked to swelling at the back of the eye (macular edema).

Interactions & Warnings

Rosiglitazone carries the FDA's strongest (boxed) warning: like other drugs in its class, it can cause or worsen congestive heart failure, a condition in which the heart cannot pump well enough and fluid backs up into the lungs and legs. It is not recommended for anyone with heart failure symptoms and must not be started in people with severe heart failure. Taking it together with insulin is not recommended, because that combination raised the risk of heart failure in trials. The drug is best known for a debate about heart attacks. A pooled analysis of many short trials suggested a higher heart attack risk than placebo, which led to years of restrictions. A later long-term trial (RECORD) and other large studies did not find more heart attacks, strokes or heart-related deaths than with metformin or sulfonylureas, and the FDA lifted its restrictions in 2015. Some studies in older adults found more heart failure and deaths with rosiglitazone than with pioglitazone, so the question was never fully settled. Other points matter for specific people. Combined with sulfonylureas or other blood sugar-lowering drugs, it can cause low blood sugar, so those doses may need lowering. Gemfibrozil, a cholesterol medicine, raises rosiglitazone levels, while rifampin, an antibiotic used for tuberculosis, lowers them. It is not started in people with active liver disease. Premenopausal women who do not ovulate regularly may start ovulating again, so unplanned pregnancy is possible; its safety in pregnancy and breastfeeding is not established.

What to Expect

Rosiglitazone works slowly. Blood sugar typically begins to fall after about 2 weeks, and the full effect takes 2 to 3 months, which is why progress is judged with HbA1c (a blood test that reflects average blood sugar over about three months) rather than day-to-day readings. Swelling and weight changes are worth tracking from the start, since they may appear before the full benefit. Today, the practical question for most people is how to replace it. Many other diabetes medicines are available, and switching is planned with a prescriber, who checks blood sugar, heart health and other medicines to choose an alternative and decide how to move from one to the next.

Questions to Ask Your Doctor

  1. 1.Since rosiglitazone is no longer sold in the US, which diabetes medicine would suit me instead, and why?
  2. 2.If I took rosiglitazone in the past, does that affect my heart, bone or eye care now?
  3. 3.Would pioglitazone be reasonable for me, or do its fluid-retention and heart failure risks rule it out?
  4. 4.Do any of my current medicines raise my risk of low blood sugar or swelling while we change treatment?

Last reviewed • Oct 2026

Educational content, not medical advice.